Norden Group LLC Makes New Investment in Waldencast plc (NASDAQ:WALD)

Norden Group LLC bought a new stake in shares of Waldencast plc (NASDAQ:WALD) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm bought 14,105 shares of the company’s stock, valued at approximately $92,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Simplicity Wealth LLC acquired a new stake in Waldencast during the 1st quarter valued at approximately $142,000. Zeno Equity Partners LLP grew its position in shares of Waldencast by 5.4% during the first quarter. Zeno Equity Partners LLP now owns 15,332,933 shares of the company’s stock worth $99,664,000 after buying an additional 780,000 shares in the last quarter. Truxt Investmentos Ltda. increased its stake in shares of Waldencast by 3.7% in the fourth quarter. Truxt Investmentos Ltda. now owns 4,075,479 shares of the company’s stock worth $44,586,000 after buying an additional 144,841 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. raised its holdings in Waldencast by 44.4% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 16,226 shares of the company’s stock valued at $178,000 after acquiring an additional 4,992 shares in the last quarter. Finally, SG Americas Securities LLC boosted its stake in Waldencast by 23.2% during the 4th quarter. SG Americas Securities LLC now owns 19,705 shares of the company’s stock valued at $216,000 after acquiring an additional 3,716 shares during the last quarter. 41.97% of the stock is owned by hedge funds and other institutional investors.

Waldencast Price Performance

Waldencast stock opened at $3.52 on Monday. Waldencast plc has a 1 year low of $3.20 and a 1 year high of $12.00. The firm’s 50-day moving average is $4.15 and its 200-day moving average is $6.19. The company has a debt-to-equity ratio of 0.22, a quick ratio of 0.82 and a current ratio of 1.71.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on WALD shares. Telsey Advisory Group restated an “outperform” rating and issued a $8.00 target price on shares of Waldencast in a research note on Tuesday, May 21st. DA Davidson cut their price objective on Waldencast from $15.50 to $6.50 and set a “buy” rating on the stock in a research note on Tuesday, May 28th.

Waldencast Profile

Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.